|
A vaccine that helps the body control the Aids virus, but does not prevent
the initial infection, shows promise in monkeys and will soon to be tested
on humans, a researcher said last month.
It is one of the first vaccines designed with a compromise in mind. As
the vaccines tested to date have had limited success in preventing infection,
scientists are now aiming at a vaccine that can dull the most lethal effects
of HIV.
Virologist Harriet Robinson, from Atlanta's Emory University, said that
a vaccine she is working on did not prevent infection in monkeys, but
did stop them from getting sick.
Robinson said: "I think we are going to be able to control HIV infection.
All the vaccinated animals became infected, but in contrast to the non-vaccinated
animals, they controlled their infections to levels seen in humans who
are long-term non-progressors." She said that 19 of the 20 animals
that got the vaccine were still controlling the virus to barely detectable
levels nearly two years later.
The label 'long-term non-progressor' is given to someone who has become
infected with HIV but never progresses to Aids, or takes a very long time
to do so. This research gives hope to the theory that a vaccine may be
able to imitate the immune system of such people and be able to control
the infection.
|
|